ARAVIVE, INC Ending Cash

Ending Cash of ARAV for past 10 years: annual, quarterly and twelve month trailing (TTM) including Ending Cash growth rates and interactive chart.

Highlights and Quick Summary

  • Ending Cash for the quarter ending September 30, 2023 was $-9.81 Million (a -44.37% decrease compared to previous quarter)
  • Year-over-year quarterly Ending Cash decreased by -138.01%
  • Annual Ending Cash for 2022 was $56.1 Million (a -9.25% decrease from previous year)
  • Annual Ending Cash for 2021 was $61.9 Million (a -1.77% decrease from previous year)
  • Annual Ending Cash for 2020 was $63 Million (a -6.79% decrease from previous year)
  • Twelve month Ending Cash ending September 30, 2023 was $36.7 Million (a 33.03% increase compared to previous quarter)
  • Twelve month trailing Ending Cash decreased by -34.54% year-over-year
Trailing Ending Cash for the last four month:
30 Sep '23 30 Jun '23 31 Mar '23 31 Dec '22
$36.7 Million $27.6 Million $26.3 Million $56.1 Million
Visit stockrow.com/ARAV for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Ending Cash of ARAVIVE, INC

Most recent Ending Cashof ARAV including historical data for past 10 years.

Interactive Chart of Ending Cash of ARAVIVE, INC

ARAVIVE, INC Ending Cash for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $-9.81 $-17.63 $38.38 – –
2022 $25.8 $-18.93 $-18.99 $68.26 $56.13
2021 $-8.09 $-7.93 $-3.25 $81.11 $61.86
2020 $6.57 $-6.09 $-0.64 $63.13 $62.97
2019 $20.16 $-3.4 $-7.2 $57.99 $67.56
2018 $-5.61 $-5.17 $-6.91 $77.07 $59.39
2017 $-37.64 $-24.57 $-21.72 $167.46 $83.53
2016 $40.72 $22.94 $-23.44 $160.93 $201.15
2015 $-15.95 $-16.66 $-15.59 $230.26 $182.07
2014 $-11.02 $-11.19 $-12.22 $205.0 $170.57
2013 $5.13 $7.2 $-2.44 $3.32 $13.29
2012 $0.32 – – – $0.4

Business Profile of ARAVIVE, INC

Sector: Healthcare
Industry: Biotechnology
© stockrow.com